1.Ooi WW., Srinivasan J. Leprosy and the peripheral nervous system: basic and clinical aspects. Muscle Nerve. 2004. 30:393–409.
Article
2.WHO. Global leprosy situation, 2010. Wkly Epidemiol Rec. 2010. 85:337.
3.Agrawal A., Pandit L., Dalal M., Shetty JP. Neurological manifestations of Hansen’s disease and their management. Clin Neurol Neurosurg. 2005. 107:445–454.
Article
4.Skacel M., Antunes SL., Rodrigues MM., Nery JA., Valentim VD., Morais RP, et al. The diagnosis of leprosy among patients with symptoms of peripheral neuropathy without cutaneous lesions: a follow-up study. Arq Neuropsiquiatr. 2000. 58:800–807.
Article
5.Pandya SS., Bhakti WS. Severe pan-sensory neuropathy in leprosy. Int J Lepr Other Mycobact Dis. 1994. 62:24–31.
6.van Brakel WH., Nicholls PG., Das L., Barkataki P., Suneetha SK., Jadhav RS, et al. The INFIR Cohort Study: Investigating prediction, detection and pathogenesis of neuropathy and reactions in leprosy, Methods and baseline results of a cohort of multibacillary leprosy patients in north India. Lepr Rev. 2005. 76:14–34.
Article
7.Khadilkar SV., Benny R., Kasegaonkar PS. Proprioceptive loss in leprous neuropathy: a study of 19 patients. Neurol India. 2008. 56:450–455.
Article
8.Rosenberg NR., Faber WR., Vermeulen M. Unexplained delayed nerve impairment in leprosy after treatment. Lepr Rev. 2003. 74:357–365.
Article
9.Ha YM. Relapse of Leprosy. Korean Lepr Bull. 1994. 27:27–29.
10.THELEP: Persisting Mycobacterium leprae among THELEP trial patients in Bamako and Chingleput. Subcommittee on Clinical Trials of the Chemotherapy of Leprosy (THELEP) Scientific Working Group of the UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases. Lepr Rev. 1987. 58:325–337.